Table 2

Correlation of NEIL3 expression with clinico-pathologic characteristics of PCA patients in Sun Yat-sen University Cancer Center (99 patients)

Clinical featuresTotal patients, nLow, n (%)High, n (%)P
Age, years1.000
 ≤ 654428 (63.6%)16 (36.4%)
 > 655535 (63.6%)20 (36.4%)
Gleason score0.036*
 ≤ 7 (3 + 4)4433 (75%)11 (25%)
 ≥ 7 (4 + 3)5530 (54.5%)25 (45.5%)
Serum PSA levels, ng/mL0.751
 ≤ 43523 (65.7%)12 (34.3%)
 > 46440 (62.5%)24 (37.5%)
T stage1.000
 T1–T22015 (75%)5 (25%)
 T3–T43628 (77.8%)8 (22.2%)
Lymph node metastasis0.654
 N03829 (76.3%)9 (23.7%)
 N12820 (71.4%)8 (28.6%)
Distant metastasis0.586
 M02115 (71.4%)6 (28.6%)
 M12214 (63.6%)8(36.4%)

Cut off value of immuno-reactivity score: 6 (> 6, High; ≤ 6, Low.); T, tumor; N, node; M, metastasis. *P < 0.05.